• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

18.02 -0.39 (-2.15%)
Streaming Delayed Price Updated: 1:37 PM EST, Mar 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 226,262
Open 17.89
Bid (Size) 18.00 (400)
Ask (Size) 18.04 (200)
Prev. Close 18.41
Today's Range 17.48 - 18.22
52wk Range 10.45 - 18.91
Shares Outstanding 353,800,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
Today 10:12 EST
As of March 3, 2026, Viatris Inc. (NASDAQ: VTRS) stands at a pivotal crossroads in its corporate evolution. Formed less than six years ago through one of the most complex healthcare mergers in recent... 
Via Finterra
Topics Economy Initial Public Offering Retirement
News headline image
5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call
February 25, 2026
Bausch + Lomb’s fourth quarter showed strong revenue growth but fell short on non-GAAP profit expectations, prompting a modestly negative market reaction. Management attributed the performance to... 
Via StockStory
Topics Earnings

Performance

YTD
+8.7%
+8.7%
1 Month
+7.4%
+7.4%
3 Month
+8.8%
+8.8%
6 Month
+21.6%
+21.6%
1 Year
+13.6%
+13.6%

More News

Read More
Bausch + Lomb Corp (NYSE:BLCO) Reports Mixed Q4 2025 Results: Revenue Beat, EPS Miss ↗
February 18, 2026
Via Chartmill
News headline image
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®
February 24, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
3 Small-Cap Stocks We Steer Clear Of
February 22, 2026
Via StockStory
News headline image
BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus
February 19, 2026
Via StockStory
News headline image
Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue
February 18, 2026
Via StockStory
News headline image
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
February 18, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb (BLCO) Q4 Earnings: What To Expect
February 16, 2026
Via StockStory
Topics World Trade
News headline image
3 Reasons to Sell BLCO and 1 Stock to Buy Instead
February 09, 2026
Via StockStory
Topics Bankruptcy Stocks
News headline image
1 Healthcare Stock to Research Further and 2 Facing Headwinds
January 29, 2026
Via StockStory
Topics Stocks
News headline image
3 Stocks Under $50 That Fall Short
January 26, 2026
Via StockStory
News headline image
3 Cash-Burning Stocks We’re Skeptical Of
January 22, 2026
Via StockStory
Topics Bankruptcy
News headline image
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
January 20, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
January 05, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Completes Refinancing of Outstanding Term B Loans
January 02, 2026
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
From Bausch + Lomb Corporation
Via Business Wire
News headline image
1 Profitable Stock to Keep an Eye On and 2 We Question
December 17, 2025
Via StockStory
News headline image
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year ↗
December 17, 2025
Via The Motley Fool
News headline image
Bausch + Lomb Announces Two Board of Directors Appointments
December 17, 2025
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
December 12, 2025
From Bausch + Lomb Corporation
Via Business Wire
News headline image
Why Bausch + Lomb (BLCO) Stock Is Trading Up Today
December 11, 2025
Via StockStory
Topics Artificial Intelligence Initial Public Offering
News headline image
3 Healthcare Stocks We Think Twice About
December 10, 2025
Via StockStory
Topics Stocks
News headline image
BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? ↗
December 03, 2025
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Why Bausch + Lomb (BLCO) Stock Is Up Today
December 02, 2025
Via StockStory
Topics Economy Initial Public Offering

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 18.02
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 03/03/26 01:37 PM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 6.37B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap